Yusuke Yamaguchi

Chuo, 1038411, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Clinical parameters among patients in Japan with anemia and non-dialysis-dependent chronic kidney disease with and without diabetes mellitus who received roxadustat.

Clinical parameters among patients in Japan with anemia and non-dialysis-dependent chronic kidney disease with and without diabetes mellitus who received roxadustat.

Journal: Clinical and experimental nephrology

Published: December 03, 2021

Factors Affecting Doses of Roxadustat Versus Darbepoetin Alfa for Anemia in Nondialysis Patients.

Factors Affecting Doses of Roxadustat Versus Darbepoetin Alfa for Anemia in Nondialysis Patients.

Journal: American journal of nephrology

Published: June 17, 2021

Multiple imputation for longitudinal data using Bayesian lasso imputation model.

Multiple imputation for longitudinal data using Bayesian lasso imputation model.

Journal: Statistics in medicine

Published: April 13, 2021

Difference in background factors between responders to gabapentin enacarbil treatment and responders to placebo: pooled analyses of two randomized, double-blind, placebo-controlled studies in Japanese patients with restless legs syndrome.

Difference in background factors between responders to gabapentin enacarbil treatment and responders to placebo: pooled analyses of two randomized, double-blind, placebo-controlled studies in Japanese patients with restless legs syndrome.

Journal: Sleep medicine

Published: April 12, 2021

Two Phase 3 Studies on Ophthalmologic Effects of Roxadustat Versus Darbepoetin.

Two Phase 3 Studies on Ophthalmologic Effects of Roxadustat Versus Darbepoetin.

Journal: Kidney international reports

Published: April 02, 2021

Authors' Reply.

Authors' Reply.

Journal: Journal of the American Society of Nephrology : JASN

Published: March 02, 2021

Phase 3 Study of Roxadustat to Treat Anemia in Non-Dialysis-Dependant CKD.

Phase 3 Study of Roxadustat to Treat Anemia in Non-Dialysis-Dependant CKD.

Journal: Kidney international reports

Published: December 22, 2020

Authors' Reply.

Authors' Reply.

Journal: Journal of the American Society of Nephrology : JASN

Published: September 11, 2020

Factors affecting the doses of roxadustat vs darbepoetin alfa for anemia treatment in hemodialysis patients.

Factors affecting the doses of roxadustat vs darbepoetin alfa for anemia treatment in hemodialysis patients.

Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy

Published: August 13, 2020

A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naïve Chronic Kidney Disease Patients Not on Dialysis.

A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naïve Chronic Kidney Disease Patients Not on Dialysis.

Journal: Nephron

Published: December 18, 2019

Borrowing external information to improve Bayesian confidence propagation neural network.

Borrowing external information to improve Bayesian confidence propagation neural network.

Journal: European journal of clinical pharmacology

Published: October 23, 2019

Multiple imputation for longitudinal data in the presence of heteroscedasticity between treatment groups.

Multiple imputation for longitudinal data in the presence of heteroscedasticity between treatment groups.

Journal: Journal of biopharmaceutical statistics

Published: July 02, 2019

Showing 1-12 of 19

Last Updated: 09/26/2026